CONMED (CNMD) Competitors

CONMED (NYSE:CNMD) and InMode (NASDAQ:INMD) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment, analyst recommendations and community ranking.

Do insiders & institutionals believe in CNMD or INMD?

55.2% of InMode shares are held by institutional investors. 7.6% of CONMED shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Do analysts rate CNMD or INMD?

CONMED currently has a consensus target price of $130.40, suggesting a potential downside of 0.97%. InMode has a consensus target price of $45.71, suggesting a potential upside of 33.78%. Given InMode's stronger consensus rating and higher possible upside, analysts plainly believe InMode is more favorable than CONMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
InMode	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Is CNMD or INMD more profitable?

InMode has a net margin of 36.05% compared to CONMED's net margin of -8.53%. InMode's return on equity of 36.35% beat CONMED's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CONMED	-8.53%	11.38%	3.66%
InMode	36.05%	36.35%	31.88%

Does the media favor CNMD or INMD?

In the previous week, InMode had 1 more articles in the media than CONMED. MarketBeat recorded 6 mentions for InMode and 5 mentions for CONMED. InMode's average media sentiment score of 1.19 beat CONMED's score of 0.70 indicating that InMode is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CONMED	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, CNMD or INMD?

CONMED has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500.

Does the MarketBeat Community believe in CNMD or INMD?

InMode received 137 more outperform votes than CONMED when rated by MarketBeat users. Likewise, 77.84% of users gave InMode an outperform vote while only 43.75% of users gave CONMED an outperform vote.

Company	Underperform	Outperform
CONMED	Outperform Votes 14 43.75%	Underperform Votes 18 56.25%
InMode	Outperform Votes 151 77.84%	Underperform Votes 43 22.16%

Which has better earnings & valuation, CNMD or INMD?

InMode has lower revenue, but higher earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CONMED	$1.05 billion	3.85	-$80.58 million	-$3.25	-40.52
InMode	$454.27 million	6.24	$161.52 million	$2.01	16.97

Summary

InMode beats CONMED on 16 of the 18 factors compared between the two stocks.